3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Tuberous Sclerosis
1
Stomach Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Myasthenia Gravis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Epilepsy
1
Diffuse Intrinsic Pontine Glioma
1
Cut-Off Value
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Endometrioid
1
Breast Neoplasms
1
Breast Cancer Lymphedema
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Interventions
Sirolimus
4
LY3295668 erbumine
3
Everolimus
3
Anticonvulsants
2
perampanel
1
clevidipine
1
brivaracetam
1
Vigabatrin
1
Topotecan
1
Therapeutic Touch
1
Temozolomide
1
TAS-119
1
Sulfasalazine
1
Sevoflurane
1
Saline Solution
1
Radiotherapy
1
Propofol
1
Paclitaxel
1
Nitrous Oxide
1
Midazolam
1
Memantine
1
Medical Marijuana
1
Lidocaine
1
Levetiracetam
1
Ketamine
1
Immunoglobulins, Intravenous
1
Glycopyrrolate
1
Gabapentin
1
Fluid Therapy
1
Fentanyl
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Epilepsy
×
Fluid Therapy
×
Clear all
NCT04987463
2024-02-08
ViRap
Children's Memorial Health Institute, Poland
Phase 2/3
Unknown
60 enrolled